Corporate donor spotlight: Exact Sciences is now Abbott

Colorectal cancer is the third most commonly diagnosed cancer in the United States, and the second most common cause of cancer death for men and women combined. Early detection is critical to improving outcomes.

Family physicians play a key role in promoting screenings and helping patients navigate their testing and treatment options. At the same time, companies like Exact Sciences is now Abbott make screening more accessible by developing newer and more reliable testing tools that are backed by science and robust clinical research.

This synergy is one reason Abbott partners with the AAFP. In doing so, Abbott also supports and advances the work of the AAFP Foundation.

Over a 30-year span, Abbott has built a powerful portfolio of innovative products and services to help detect cancer earlier and facilitate smarter treatment decisions. The company enhances the impact of these products by collaborating directly with the AAFP to provide family medicine physicians with the most up-to-date information about colorectal cancer, including concerning trends, clinical guidelines for screening and strategies for personalized prevention based on patient risk.

The AAFP Foundation advances physician education, leadership development, research and community-focused programs that improve access to care and health outcomes,” Abbott said. “Supporting those efforts aligns with our shared commitment to helping family physicians deliver high-quality preventive care and improve the health of the communities they serve.”

On behalf of the AAFP Foundation, we thank Abbott for helping to ensure that individuals have better access to timely and accurate tools for early cancer detection and informed decision-making. It is truly lifesaving work, and we are proud to be part of this mission.